These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 10221702
21. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding. Hickey M, Dwarte D, Fraser IS. Hum Reprod; 2000 Jul; 15(7):1509-14. PubMed ID: 10875858 [Abstract] [Full Text] [Related]
22. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception. Runic R, Schatz F, Krey L, Demopoulos R, Thung S, Wan L, Lockwood CJ. J Clin Endocrinol Metab; 1997 Jun; 82(6):1983-8. PubMed ID: 9177417 [Abstract] [Full Text] [Related]
23. Perivascular smooth muscle alpha-actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding. Rogers PA, Plunkett D, Affandi B. Hum Reprod; 2000 Aug; 15 Suppl 3():78-84. PubMed ID: 11041224 [Abstract] [Full Text] [Related]
24. A review of the endometrial changes in Norplant users. Wan LS. Ann N Y Acad Sci; 1997 Sep 26; 828():108-10. PubMed ID: 9329828 [Abstract] [Full Text] [Related]
25. Oestrogen treatment for increased bleeding in Norplant users: preliminary results. Witjaksono J, Lau TM, Affandi B, Rogers PA. Hum Reprod; 1996 Oct 26; 11 Suppl 2():109-14. PubMed ID: 8982752 [Abstract] [Full Text] [Related]
26. [Study on relationship between endometrium laminin expression and irregular uterine bleeding in Norplant users]. Shi X, Han X, Weng J. Zhonghua Fu Chan Ke Za Zhi; 2000 Mar 26; 35(3):169-71. PubMed ID: 11775898 [Abstract] [Full Text] [Related]
27. Progesterone receptor in Norplant endometrium. Lau TM, Witjaksono J, Rogers PA. Hum Reprod; 1996 Oct 26; 11 Suppl 2():90-4. PubMed ID: 8982750 [Abstract] [Full Text] [Related]
28. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Critchley HO, Wang H, Kelly RW, Gebbie AE, Glasier AF. Hum Reprod; 1998 May 26; 13(5):1210-7. PubMed ID: 9647549 [Abstract] [Full Text] [Related]
29. Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users. Marbaix E, Vekemans M, Galant C, Rigot V, Lemoine P, Dubois D, Picquet C, Henriet P, Twagirayezu P, Sufi S, Eeckhout Y, Courtoy PJ. Hum Reprod; 2000 Aug 26; 15 Suppl 3():120-34. PubMed ID: 11041228 [Abstract] [Full Text] [Related]
30. Microvascular density in conditions of endometrial atrophy. Hickey M, Lau TM, Russell P, Fraser IS, Rogers PA. Hum Reprod; 1996 Sep 26; 11(9):2009-13. PubMed ID: 8921081 [Abstract] [Full Text] [Related]
31. The structure of endometrial microvessels. Hickey M, Fraser IS. Hum Reprod; 2000 Aug 26; 15 Suppl 3():57-66. PubMed ID: 11041222 [Abstract] [Full Text] [Related]
32. A three-dimensional study of endometrial microvessels in women using the contraceptive subdermal levonorgestrel implant system, norplant. Simbar M, Manconi F, Markham R, Hickey M, Fraser IS. Micron; 2004 Aug 26; 35(7):589-95. PubMed ID: 15219905 [Abstract] [Full Text] [Related]
33. Angiogenic effects of norplant contraception on endometrial histology and uterine bleeding. Pritts EA, Ryan IP, Mueller MD, Lebovic DI, Shifren JL, Zaloudek CJ, Korn AP, Darney PD, Taylor RN. J Clin Endocrinol Metab; 2005 Apr 26; 90(4):2142-7. PubMed ID: 15623808 [Abstract] [Full Text] [Related]
34. Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding. Hickey M, Pillai G, Higham JM, Sullivan M, Horncastle D, Doherty D, Stamp G. Hum Reprod; 2003 May 26; 18(5):1100-6. PubMed ID: 12721191 [Abstract] [Full Text] [Related]
35. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system. Möller B, Rönnerdag M, Wang G, Odlind V, Olovsson M. Hum Reprod; 2005 May 26; 20(5):1410-7. PubMed ID: 15760960 [Abstract] [Full Text] [Related]
36. Bcl-2, Fas and caspase 3 expression in endometrium from levonorgestrel implant users with and without breakthrough bleeding. Rogers PA, Lederman F, Plunkett D, Affandi B. Hum Reprod; 2000 Aug 26; 15 Suppl 3():152-61. PubMed ID: 11041231 [Abstract] [Full Text] [Related]
37. Benefits of vitamin E supplementation to Norplant users--in vitro and in vivo studies. Subakir SB, Setiadi E, Affandi B, Pringgoutomo S, Freisleben HJ. Toxicology; 2000 Aug 07; 148(2-3):173-8. PubMed ID: 10962136 [Abstract] [Full Text] [Related]
38. Norplant users with irregular bleeding. Ultrasonographic assessment and evaluation of serum concentrations of estradiol and progesterone. Kaewrudee S, Taneepanichskul S. J Reprod Med; 2000 Dec 07; 45(12):983-6. PubMed ID: 11153258 [Abstract] [Full Text] [Related]
39. Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implants. Faúndes A, Alvarez F, Brache V, Cochón L. Hum Reprod; 1998 Jan 07; 13(1):188-91. PubMed ID: 9512255 [Abstract] [Full Text] [Related]
40. A comparative study of Cyclofem and depot medroxyprogesterone acetate (DMPA) effects on endometrial vasculature. Simbar M, Tehrani FR, Hashemi Z, Zham H, Fraser IS. J Fam Plann Reprod Health Care; 2007 Oct 07; 33(4):271-6. PubMed ID: 17925114 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]